Your browser doesn't support javascript.
loading
Idelalisib addition has neutral to beneficial effects on quality of life in bendamustine/rituximab-treated patients: results of a phase 3, randomized, controlled trial.
Montillo, Marco; Illés, Árpád; Robak, Tadeusz; Pristupa, Alexander S; Wach, Malgorzata; Egyed, Miklós; Delgado, Julio; Jurczak, Wojciech; Morschhauser, Franck; Schuh, Anna; Eradat, Herbert; Shreay, Sanatan; Barrientos, Jacqueline C; Zelenetz, Andrew D.
Afiliación
  • Montillo M; Department of Hematology, Niguarda Cancer Center, Niguarda Hospital, Piazza Ospedale Maggiore, 3, 20162, Milan, Italy. marco.montillo@ospedaleniguarda.it.
  • Illés Á; Department of Hematology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
  • Robak T; Department of Hematology, Medical University of Lodz and Copernicus Memorial Hospital, Lodz, Poland.
  • Pristupa AS; Department of Hematology, Ryazan Regional Clinical Hospital, Ryazan, Russia.
  • Wach M; Department Hemato-Oncology and Bone Marrow Transplantation, Medical University of Lublin, Lublin, Poland.
  • Egyed M; Department of Hematology, Somogy County Kaposi Mor Hospital, Kaposvar, Hungary.
  • Delgado J; Department of Hematology, Hospital Clínic, Barcelona, Spain.
  • Jurczak W; Maria Sklodowska Curie Institute of Oncology, Krakow, Poland.
  • Morschhauser F; CHRU Lille, Unité GRITA, Department of Hematology, Université de Lille, Lille, France.
  • Schuh A; University of Oxford, Oxford Cancer and Haematology Centre, Churchill Hospital, Oxford, UK.
  • Eradat H; Division of Hematology-Oncology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
  • Shreay S; Gilead Sciences, Inc., Foster City, CA, USA.
  • Barrientos JC; Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA.
  • Zelenetz AD; Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Health Qual Life Outcomes ; 17(1): 173, 2019 Nov 15.
Article en En | MEDLINE | ID: mdl-31729982

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Purinas / Calidad de Vida / Leucemia Linfocítica Crónica de Células B / Protocolos de Quimioterapia Combinada Antineoplásica / Quinazolinonas / Clorhidrato de Bendamustina / Rituximab Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Health Qual Life Outcomes Asunto de la revista: SAUDE PUBLICA Año: 2019 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Purinas / Calidad de Vida / Leucemia Linfocítica Crónica de Células B / Protocolos de Quimioterapia Combinada Antineoplásica / Quinazolinonas / Clorhidrato de Bendamustina / Rituximab Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Health Qual Life Outcomes Asunto de la revista: SAUDE PUBLICA Año: 2019 Tipo del documento: Article País de afiliación: Italia